JONATHAN DORE: Open Payments
NPI 1750887329 · CLIFTON PARK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$820 in 46 payments from 16 companies in 2025. Trend: 2023 $1,203 · 2024 $1,261 · 2025 $820
Food & beverage: $820
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $169 |
| AstraZeneca Pharmaceuticals LP | 6 | $104 |
| Amgen Inc. | 5 | $98 |
| Phathom Pharmaceuticals, Inc. | 5 | $56 |
| GlaxoSmithKline, LLC. | 3 | $56 |
| Otsuka America Pharmaceutical, Inc. | 2 | $51 |
| Viatris Specialty LLC | 2 | $48 |
| Abbott Laboratories | 2 | $42 |
| Novo Nordisk Inc | 2 | $40 |
| Exeltis, USA Inc. | 2 | $36 |
Products named: OTEZLA, QULIPTA, UBRELVY, VOQUEZNA, REXULTI, YUPELRI, FARXIGA, SHINGRIX.
Industry payments across NY — which companies pay providers there.
